AI driven biopharmaceutical startup raises $10M in series A financing
20-Mar-2018 -
twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced that it has raised $10 million in Series A financing led by SoftBank Ventures, a SoftBank Group early stage venture capital arm. Joining SoftBank Ventures is the Andreessen Horowitz Bio Fund and OS Fund. The ...
drug candidates
drug development
drug discovery
+4